Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy
Claudio Marasca, Angelo Ruggiero, Matteo Megna, Maria Carmela Annunziata, Gabriella Fabbrocini
Abstract
"Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy." Journal of Dermatological Treatment, 33(1), p. 592 Disclosure statementNo potential conflict of interest was reported by the author(s).
Topics & Concepts
Hidradenitis suppurativaMedicineCoronavirus disease 2019 (COVID-19)DermatologyReferral2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Family medicineInternal medicineDiseaseVirologyInfectious disease (medical specialty)OutbreakHidradenitis Suppurativa and TreatmentsChemotherapy-related skin toxicityCOVID-19 and healthcare impacts